Skip to content

Why are biomarkers important in achieving early diagnosis of Alzheimer's disease?

Prof Henrik Zetterberg, Sweden

Alzheimer's disease hub

Research and DiagnosticsBiomarkers

 

Why are biomarkers important in achieving early diagnosis of Alzheimer's disease?

 

Prof Henrik Zetterberg, Sweden

March 19, 2022

 


 

We had the opportunity to speak to biomarker researcher and expert, Professor Henrik Zetterberg at ADPD 2022, on why these tools are so important in achieving early diagnosis of Alzheimer's disease, which may lead to better patient outcomes.

 

 

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.

Leave Site

You are Leaving the Global Medically Site

By following this link, you are being redirected to another Roche page.